BUENOS AIRES (Reuters) - Argentina has started clinical trials on treating COVID-19 using hyperimmune serum developed with antibodies from horses, authorities from the laboratory involved said on Wednesday.
The serum, produced by biotechnology company Inmunova, is obtained by injecting a SARS-CoV-2 protein, which causes the animal to generate a large amount of neutralizing antibodies. Plasma is then extracted from the horse, purified and processed.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!